These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9531961)

  • 21. Streptococcal M protein.
    Fischetti VA
    Sci Am; 1991 Jun; 264(6):58-65. PubMed ID: 1857955
    [No Abstract]   [Full Text] [Related]  

  • 22. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
    Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
    J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-linked immunosorbent assay for streptococcal M protein antibodies.
    Russell H; Facklam RR; Edwards LR
    J Clin Microbiol; 1976 May; 3(5):501-5. PubMed ID: 777024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.
    Basma H; Norrby-Teglund A; McGeer A; Low DE; El-Ahmedy O; Dale JB; Schwartz B; Kotb M
    Infect Immun; 1998 May; 66(5):2279-83. PubMed ID: 9573118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci.
    Brandt ER; Hayman WA; Currie B; Carapetis J; Wood Y; Jackson DC; Cooper J; Melrose WD; Saul AJ; Good MF
    Immunology; 1996 Nov; 89(3):331-7. PubMed ID: 8958044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immunogenicity of group A streptococcal M-related proteins.
    Dale JB; Niedermeyer SE; Agbaosi T; Hysmith ND; Penfound TA; Hohn CM; Pullen M; Bright MI; Murrell DS; Shenep LE; Courtney HS
    Clin Vaccine Immunol; 2015 Mar; 22(3):344-50. PubMed ID: 25630406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing Vaccine Efficacy by Engineering a Complex Synthetic Peptide To Become a Super Immunogen.
    Nordström T; Pandey M; Calcutt A; Powell J; Phillips ZN; Yeung G; Giddam AK; Shi Y; Haselhorst T; von Itzstein M; Batzloff MR; Good MF
    J Immunol; 2017 Oct; 199(8):2794-2802. PubMed ID: 28904125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface.
    Dinkla K; Sastalla I; Godehardt AW; Janze N; Chhatwal GS; Rohde M; Medina E
    Microbes Infect; 2007 Jul; 9(8):922-31. PubMed ID: 17544803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquisition of group A streptococcal M protein antibodies.
    Quinn RW; Vander Zwaag R; Lowry PN
    Pediatr Infect Dis; 1985; 4(4):374-8. PubMed ID: 3895177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein.
    Beachey EH; Tartar A; Seyer JM; Chedid L
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2203-7. PubMed ID: 6425829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of emm gene sequencing and T antigen serology for typing group A streptococcal systemic isolates. Survey of random and outbreak-related isolates.
    Beall B; Facklam R; Hoenes T; Schwartz B
    Adv Exp Med Biol; 1997; 418():307-11. PubMed ID: 9331658
    [No Abstract]   [Full Text] [Related]  

  • 32. Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin.
    Vashishtha A; Fischetti VA
    J Immunol; 1993 May; 150(10):4693-701. PubMed ID: 8482854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever.
    Bisno AL; Berrios X; Quesney F; Monroe DM; Dale JB; Beachey EH
    Infect Immun; 1982 Nov; 38(2):573-9. PubMed ID: 6754620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vimentin-cross-reactive epitope of type 12 streptococcal M protein.
    Kraus W; Seyer JM; Beachey EH
    Infect Immun; 1989 Aug; 57(8):2457-61. PubMed ID: 2473037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial.
    Kotloff KL; Corretti M; Palmer K; Campbell JD; Reddish MA; Hu MC; Wasserman SS; Dale JB
    JAMA; 2004 Aug; 292(6):709-15. PubMed ID: 15304468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The enhancement of the immunogenicity of streptococcal group-A M protein by conjugation with a synthetic polyelectrolyte].
    Semenova EN; Sanina VIu; Nekrasov AV; Puchkova NG; Liampert IM
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Nov; (11):56-9. PubMed ID: 1725839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulins inhibit adherence and internalization of Streptococcus pyogenes to human pharyngeal cells.
    Fluckiger U; Fischetti VA
    Adv Exp Med Biol; 1997; 418():909-11. PubMed ID: 9331796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic epitope mapping of the M24 protein of Streptococcus pyogenes: implications for serodiagnosis of rheumatic fever.
    Norton RE; Heuzenroeder M; Manning PA
    FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):267-71. PubMed ID: 9116645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
    Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
    Bronze MS; Courtney HS; Dale JB
    J Immunol; 1992 Feb; 148(3):888-93. PubMed ID: 1370521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.